Large Language Models (LLM) like ChatGPT have taken the world by storm, with everyone from researchers to tech enthusiasts excited about the almost limitless potential of these models. And yes, I’ll admit it that…
Continue Reading
As the healthcare industry continues to evolve and transform with providers facing increasing financial burdens and dynamic patient expectations, Signify Research has had the opportunity to speak to 100s of C-suite health IT executives…
Continue Reading
Life sciences organizations have access to more data than ever before. When they leverage that existing data during their research and development (R&D) process, organizations can drive more efficient drug development.
Innovation and regulatory approval…
As a new therapeutic technique based on digital technology, the commercialization and clinical application of digital therapeutics (DTx) are increasing, and the demand for expansion to new clinical fields is remarkably high. However, the…
Continue Reading
Laboratory medicine aggressively employs new technology to enhance clinical decision-making, disease monitoring, and patient safety. The potential for innovation to transform healthcare systems and laboratory medicine is enormous, and it has the potential to…
Continue Reading
Dr. Tejas Joshi, Director of Liver Diseases and Assistant Professor at Marshall University School of Medicine in Huntington, WV joins eHealth Radio and the Liver Health and Health News Channels.
Listen to interview with…
By Hannah Nelson
March 03, 2023 – The Patient-Centered Outcomes Research Institute (PCORI) has kicked off a multiyear comparative clinical effectiveness research initiative with an initial investment of $50 million.
The Health Systems Implementation Initiative…
By Shania Kennedy
March 03, 2023 – Researchers at the University of Houston have received a $933,812 grant from the National Cancer Institute (NCI) to develop a computational framework to support collaboration between radiology…
MorphoSys, a company whose research has yielded programs placed with big pharmaceutical companies and upstart biotechs, is stopping all preclinical work to focus on cancer, particularly a late-stage drug candidate it acquired in a…
Continue Reading
What You Should Know:– C2i Genomics, a cancer intelligence company, today announced a collaboration with Riken Genesis Co., Ltd. (RG), a company specializing in providing the service of personalized medicine based on contract analysis…
Continue Reading
